The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)
Open accessAbstract
Reactive oxygen species (ROS) have an established role in inflammation and host defense, as they kill intracellular bacteria and have been shown to activate the NLRP3 inflammasome. Here, we find that ROS generated by mitochondrial respiration are important for normal lipopolysaccharide (LPS)-driven production of several proinflammatory cytokines and for the enhanced responsiveness to LPS seen in cells from patients with tumor necrosis factor receptor-associated periodic syndrome (TRAPS), an autoinflammatory disorder caused by missense mutations in the type 1 TNF receptor (TNFR1). We find elevated baseline ROS in both mouse embryonic fibroblasts and human immune cells harboring TRAPS-associated TNFR1 mutations. A variety of antioxidants dampen LPS-induced MAPK phosphorylation and inflammatory cytokine production. However, gp91phox and p22phox reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits are dispensable for inflammatory cytokine production, indicating that NADPH oxidases are not the source of proinflammatory ROS. TNFR1 mutant cells exhibit altered mitochondrial function with enhanced oxidative capacity and mitochondrial ROS generation, and pharmacological blockade of mitochondrial ROS efficiently reduces inflammatory cytokine production after LPS stimulation in cells from TRAPS patients and healthy controls. These findings suggest that mitochondrial ROS may be a novel therapeutic target for TRAPS and other inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these mtROS also contribute to oxidative stress through the oxidation of surrounding biomolecules, eventually culminating in uncontrolled inflammation, production of neoantigens, DNA damage and DNA mutations60–63”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Not surprisingly, the NLRP3 inflammasome was, with exception for IL-1β, not involved in cytokine secretion as NLRP3-, Caspase-1- and Caspase 1l-deficient macrophages showed normal secretion of TNF and IL-6 (see Section 4.3).”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
Experimental — accuracy not yet measuredIn the citing paper
“TNFR1-deficient macrophages stimulated with LPS showed enhanced secretion of IL-6, TNF and IL-1β.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
In the citing paper
“MEF treated with LPS and MitoQ showed reduced levels of IL-6, which, unfortunately, is the only connection between mtROS and cytokine secretion investigated in this study.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
In the citing paper
“Moreover, macrophages lacking the p22phox subunit showed cytokine secretion similar to Nox2-deficient macrophages, nicely showing that Nox enzymes were dispensable for cytokine secretion after LPS stimulation.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [63]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydroperoxide metabolism in mammalian organs.
Chance, B., Sies, H., & Boveris, A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.527 · Cited by 5,827 · cited 2×
“These results identify mitochondria, which are a major source of physiological cellular ROS (Chance et al., 1979; Balaban et al., 2005), in the genesis of ROS that drive inflammation.”
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 2×
“Although it has recently been shown that mitochondrial damage and inhibition of mitophagy can activate the NLRP3 inflammasome and IL-1 cleavage in a ROS-dependent manner (Zhou et al., 2010b), our results suggest a more general role for mitochondrial ROS in the induction of inflammatory cytokines upstream of inflammas…”
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · cited 2×
“These results identify mitochondria, which are a major source of physiological cellular ROS (Chance et al., 1979; Balaban et al., 2005), in the genesis of ROS that drive inflammation.”
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 2×
“Mice with a null allele of the gene involved in X-linked CGD, gp91phox, which encodes the 91-kD subunit of the burst (Nathan, 2006).”
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · cited 6×
“ROS have been implicated in the activation of the NLRP3 inflammasome, which results in IL-1 processing and secretion through activation of caspase-1 (Cruz et al., 2007; Zhou et al., 2010a).”
InfluentialInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · cited 1×
“…oxygen species (ROS) have been implicated in inflammatory diseases including rheumatoid arthritis (Filippin et al., 2008), multiple sclerosis (Gilgun-Sherki et al., 2004), thyroiditis (Burek and Rose, 2008), and type 1 diabetes (Chen et al., 2008).”
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,655
Cited by
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
“Interestingly, patients with tumor necrosis factor receptor-associated periodic syndrome (TRAPS) have heightened responsiveness to LPS, due to increased mitochondrial ROS production, which promotes inflammation, again suggesting that redox biology, and not oxidative stress, is regulating inflammatory diseases [90].”
BackgroundReactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
“Monocytes and neutrophils isolated from TRAPS patients showed elevated baseline levels of mitochondrial ROS compared with healthy donors and also had constitutive and prolonged activation of JNK and p38 MAPK on LPS challenge (48).”
InfluentialPhysiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Signal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322
Cellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Self-citationMetabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692
Incalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
“Radiation therapy also causes impairment of endothelium-dependent vasodilation in exposed arteries by reducing endothelium-derived NO, with subsequent platelet aggregation, increased adhesion leukocytes to the endothelial surface and promotion of growth of vascular smooth cells [13].”
BackgroundInfluentialSena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338
“TLR signaling through mROS appears to be important in human disease because cells from individuals with TRAPS (tumor-necrosisfactor-receptor-associated periodic syndrome) exhibit greater responsiveness to LPS as a result of increased mROS production (Bulua et al., 2011).”
Reactive oxygen species and mitochondria: A nexus of cellular homeostasis
Dan Dunn, J., Alvarez, L. A., Zhang, X., & Soldati, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.005 · Cited by 1,203
Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production
Doenst, T., Nguyen, T. D., & Abel, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300376 · Cited by 1,111
TNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008
Mitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
“Mitochondrial ROS (mtROS) Alternatively, there is an emerging role for mtROS in the mechanism of NLRP3 inflammasome activation (21,155).”
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Inflammasomes and Their Roles in Health and Disease
Lamkanfi, M., & Dixit, V. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155745 · Cited by 935
“Inflammasome components such as NLRP3, caspase-11, and proIL-1β are expressed at relatively low levels, and priming with NFκB-activating inflammatory cytokines, TLR ligands, and other PAMPs is required for their mRNAs to be induced (Bauernfeind et al. 2011, Bulua et al. 2011, Kayagaki et al. 2011).”
BackgroundLi, X., Fang, P., Mai, J., Choi, E. T., Wang, H., & Yang, X.-F. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-19 · Cited by 812
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD
Datta, S., Cano, M., Ebrahimi, K., Wang, L., & Handa, J. T. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.03.002 · Cited by 802
“…after excess metabolism (Brunelle et al., 2005; Guzy et al., 2005), response to hypoxia via HIF-1α (Guzy et al., 2005), regulation of autophagy through ATF4 (Scherz-Shouval et al., 2007), and regulation of inflammatory responses (Bulua et al., 2011; Nakahira et al., 2011; Zhou et al., 2011).”
BackgroundSedger, L. M., & McDermott, M. F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.016 · Cited by 771
“However, abnormal ER retention [131], mitochrondrial reactive oxygen species [132], ER stress, and the stress response to ‘‘unfolded’’ or aggregated proteins also contribute to TRAPS pathogenesis [133]; for review see [134].”
BackgroundMitochondrial reactive oxygen species drive proinflammatory cytokine production
Naik, E., & Dixit, V. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110367 · Cited by 783
Liu, J., Han, X., Zhang, T., Tian, K., Li, Z., & Luo, F. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01512-7 · Cited by 660
“In fact, dysregulation of the NLRP3 inflammasome is related to the pathogenesis of numerous inflammatory disorders, such as diabetic nephropathy (DN) [36], tumor necrosis factor receptor-associated periodic syndrome (TRAPS) [37], OA [38], and Alzheimer’s disease (AD) [39].”
BackgroundInterrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734
“Interestingly, patients with tumor necrosis factor receptor-associated periodic syndrome, an autoinflammatory disorder caused by missense mutations in the type 1 tumor necrosis factor receptor, have elevated mitochondrial ROS levels, which are responsible for the stronger inflammatory responses to LPS (36).”
BackgroundDouda, D. N., Khan, M. A., Grasemann, H., & Palaniyar, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414055112 · Cited by 693
“Proc Natl Acad Sci USA 110(21):8674–8679.”
BackgroundPathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Starobova, H., & Vetter, I. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00174 · Cited by 648
“Furthermore, ROS can cause the activation of apoptotic pathways (Cashman and Hoke, 2015) and increase production of pro-inflammatory mediators (Bulua et al., 2011).”
BackgroundWeidinger, A., & Kozlov, A. (2015) · Biomolecules · doi:10.3390/biom5020472 · Cited by 646
“[57] showed that”
Amino Assets: How Amino Acids Support Immunity
Kelly, B., & Pearce, E. L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.010 · Cited by 643
Reactive oxygen species (ROS) in macrophage activation and function in diabetes
Rendra, E., Riabov, V., Mossel, D. M., Sevastyanova, T., Harmsen, M. C., & Kzhyshkowska, J. (2019) · Immunobiology · doi:10.1016/j.imbio.2018.11.010 · Cited by 636
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
“While Nox enzymes were not involved in proinflammatory signaling in response to bacterial infection or LPS of macrophages [30,63], Allan and colleagues demonstrated an important role for Nox2-derived extracellular ROS in antigen presentation [232].”
BackgroundInfluentialYun, J., & Finkel, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.011 · Cited by 626
Hypoxia, oxidative stress and inflammation
McGarry, T., Biniecka, M., Veale, D. J., & Fearon, U. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.042 · Cited by 601
Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., & Hornung, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100613 · Cited by 617
“Furthermore, independent evidence also exists that ROS activate proinflammatory transcription factors (19, 20) and that ROS production positively regulates proinflammatory gene expression in various innate immune signaling pathways (14, 21).”
BackgroundThe glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
Shirai, T., Nazarewicz, R. R., Wallis, B. B., Yanes, R. E., Watanabe, R., Hilhorst, M., Tian, L., Harrison, D. G., Giacomini, J. C., Assimes, T. L., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150900 · Cited by 543
“Elevated mtROS levels correlate with persistent activation of JNK and p38 in periodic fever syndromes (Bulua et al., 2011).”
BackgroundMitochondrial dysfunction and the inflammatory response
López-Armada, M. J., Riveiro-Naveira, R. R., Vaamonde-García, C., & Valcárcel-Ares, M. N. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.01.003 · Cited by 530
“In other cell types, mitochondrial impairment also increased the generation of ROS, resulting in potentiation of cytotoxicity or inflammatory cell accumulation (Bulua et al., 2011; Schulze-Osthoff et al., 1993).”
BackgroundLeyane, T. S., Jere, S. W., & Houreld, N. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137273 · Cited by 469
Mitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
Park, J., Min, J.-S., Kim, B., Chae, U.-B., Yun, J. W., Choi, M.-S., Kong, I.-K., Chang, K.-T., & Lee, D.-S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.016 · Cited by 529
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
“These factors potentiate MAPK signaling that also drives the production of inflammatory mediators (56).”
BackgroundReactive Oxygen Species in the Immune System
Yang, Y., Bazhin, A. V., Werner, J., & Karakhanova, S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.755176 · Cited by 509
“On the contrary, mitochondrial ROS have also been shown to trigger pro-inflammatory cytokine production in an inflammasome-independent manner [47].”
BackgroundCancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
Trinchieri, G. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075008 · Cited by 511
Trained immunity — basic concepts and contributions to immunopathology
Ochando, J., Mulder, W. J. M., Madsen, J. C., Netea, M. G., & Duivenvoorden, R. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00633-5 · Cited by 453
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
De Benedetti, F., Gattorno, M., Anton, J., Ben-Chetrit, E., Frenkel, J., Hoffman, H. M., Koné-Paut, I., Lachmann, H. J., Ozen, S., Simon, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706314 · Cited by 486
“≥12 to <18 yr 5 (16) 11 (34) 10 (27) 7 (20) 5 (23) 5 (21)”
Self-citationReactive Oxygen Species in Macrophages: Sources and Targets
Canton, M., Sánchez-Rodríguez, R., Spera, I., Venegas, F. C., Favia, M., Viola, A., & Castegna, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734229 · Cited by 449
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal
Mills, E. L., & O'Neill, L. A. (2016) · European Journal of Immunology · doi:10.1002/eji.201445427 · Cited by 458
Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
Fearon, U., Canavan, M., Biniecka, M., & Veale, D. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.69 · Cited by 439
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
Pillai, V. B., Samant, S., Sundaresan, N. R., Raghuraman, H., Kim, G., Bonner, M. Y., Arbiser, J. L., Walker, D. I., Jones, D. P., Gius, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7656 · Cited by 445
Mitochondrial control of immunity: beyond ATP
Mehta, M. M., Weinberg, S. E., & Chandel, N. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.66 · Cited by 396
Manthiram, K., Zhou, Q., Aksentijevich, I., & Kastner, D. L. (2017) · Nature Immunology · doi:10.1038/ni.3777 · Cited by 399
Self-citationCellular and molecular roles of reactive oxygen species in wound healing
Hunt, M., Torres, M., Bachar-Wikstrom, E., & Wikstrom, J. D. (2024) · Communications Biology · doi:10.1038/s42003-024-07219-w · Cited by 324
“Although NOXs are essential for macrophage activation, they have been shown to be dispensable for M1 macrophage-mediated proin-fl ammatory cytokine production 79 .”
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
Signal Transduction by Mitochondrial Oxidants
Finkel, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.271999 · Cited by 390
TRPM2 links oxidative stress to NLRP3 inflammasome activation
Zhong, Z., Zhai, Y., Liang, S., Mori, Y., Han, R., Sutterwala, F. S., & Qiao, L. (2013) · Nature Communications · doi:10.1038/ncomms2608 · Cited by 375
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 374
García-Sánchez, A., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2082145 · Cited by 331
Manganese Superoxide Dismutase: Guardian of the Powerhouse
Holley, A. K., Bakthavatchalu, V., Velez-Roman, J. M., & St. Clair, D. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12107114 · Cited by 358
“Scavenging of mitochondrial ROS inhibited LPS-dependent cytokine production [211].”
BackgroundGiorgi, C., Missiroli, S., Patergnani, S., Duszynski, J., Wieckowski, M. R., & Pinton, P. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6223 · Cited by 328
“To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars Furthermore, antioxidants specifically targeting mitochondria appear to block inflammasome activation and in-flammation in general (20, 124).”
IL-1 Blockade in Autoinflammatory Syndromes
Jesus, A. A., & Goldbach-Mansky, R. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061512-150641 · Cited by 326
Arima, K., Kinoshita, A., Mishima, H., Kanazawa, N., Kaneko, T., Mizushima, T., Ichinose, K., Nakamura, H., Tsujino, A., Kawakami, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106015108 · Cited by 327
“Increased p-p38 levels are in agreement with the proposed mechanism for TNFR1-associated periodic syndrome (TRAPS), which is another autoinflammatory syndrome (40).”
BackgroundER stress activates the NLRP3 inflammasome via an UPR-independent pathway
Menu, P., Mayor, A., Zhou, R., Tardivel, A., Ichijo, H., Mori, K., & Tschopp, J. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.132 · Cited by 322
“As signaling pathways triggered by the UPR appeared to be dispensable, we next investigated the role of alternative signaling pathways that were shown to emanate from a stressed ER.2 ER stress is proposed to trigger NF-kB activation through the interaction between IRE1a and the IKK complex via the adaptor TRAF2.”
BackgroundResultInfluentialDaiber, A., Xia, N., Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Münzel, T., & Li, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010187 · Cited by 297
Mitochondria, Oxidative Stress and Innate Immunity
Chen, Y., Zhou, Z., & Min, W. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01487 · Cited by 315
“As reviewed above, mtROS directly contribute to inflammatory cytokine production and innate immune responses. mtROS can directly activate adenosine monophosphate-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPKs) (Bulua et al., 2011).”
BackgroundMetabolic Modulation in Macrophage Effector Function
Diskin, C., & Pålsson-McDermott, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00270 · Cited by 291
“These findings are not restricted to mice as immune cells isolated from patients suffering from TNF receptor-associated periodic syndrome (TRAPS) were found to have elevated mROS (96).”
BackgroundLi, X., Qi, M., Sun, X., Weir, M. D., Tay, F. R., Oates, T. W., Dong, B., Zhou, Y., Wang, L., & Xu, H. H. K. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.023 · Cited by 279
Barcoded viral tracing of single-cell interactions in central nervous system inflammation
Clark, I. C., Gutiérrez-Vázquez, C., Wheeler, M. A., Li, Z., Rothhammer, V., Linnerbauer, M., Sanmarco, L. M., Guo, L., Blain, M., Zandee, S. E. J., et al. (2021) · Science · doi:10.1126/science.abf1230 · Cited by 285
“We identified a role for Sema4DPlexinB1 and Sema4D-PlexinB2 interactions in the microglial control of astrocytes during EAE and MS. Sema4D is described to participate in neurodevelopment (82, 83), T cell Clark et al., Science 372, eabf1230 (2021) 23 April 2021 12 of 15 p-p85α p-p55α p-AKT (Thr308) TNFα + IL-1β - - A38…”
BackgroundInfluentialde Jesus, A. A., Canna, S. W., Liu, Y., & Goldbach-Mansky, R. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112227 · Cited by 282
“TRAPS patient cells are hyperinflammatory, as they spontaneously activate JNK and p38 MAP kinases (MAPKs) (89) and show exaggerated, TNF-independent mitochondrial reactive oxygen species production that may activate the IL-1 pathway (90, 91).”
BackgroundMitochondrial dynamics modulate the expression of pro‐inflammatory mediators in microglial cells
Park, J., Choi, H., Min, J., Park, S., Kim, J., Park, H., Kim, B., Chae, J., Yim, M., & Lee, D. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12361 · Cited by 274
Self-citationDaiber, A., Di Lisa, F., Oelze, M., Kröller‐Schön, S., Steven, S., Schulz, E., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13403 · Cited by 269
“Of note, mitochondrial ROS were reported to activate the NLRP3 inflammasome (Zhou et al., 2011), promote the expression of proinflammatory cytokines in LPS-induced sepsis (Bulua et al., 2011) and improve bactericidal activity (West et al., 2011) (for review see (Ortona et al., 2014)).”
BackgroundA clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin
Ozen, S., & Bilginer, Y. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.174 · Cited by 263
Ranneh, Y., Ali, F., Akim, A. M., Hamid, H. A., Khazaai, H., & Fadel, A. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0285-9 · Cited by 250
“Using cells from tumor necrosis factor receptor-associated periodic syndrome (TRAPS) patients showed that mitochondrial ROS affect significantly on the promotion of transcriptional factors of pro-inflammatory cytokines [58].”
BackgroundInfluentialCameron, A. M., Castoldi, A., Sanin, D. E., Flachsmann, L. J., Field, C. S., Puleston, D. J., Kyle, R. L., Patterson, A. E., Hässler, F., Buescher, J. M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0336-y · Cited by 269
Wang, Y., Wang, G. Z., Rabinovitch, P. S., & Tabas, I. (2014) · Circulation Research · doi:10.1161/circresaha.114.302153 · Cited by 267
“ies suggesting that nonmitochondrial ROS can inhibit proinflammatory cytokine induction.(37,38) Thus, mitoOS has distinct”
BackgroundGeng, J., Sun, X., Wang, P., Zhang, S., Wang, X., Wu, H., Hong, L., Xie, C., Li, X., Zhao, H., et al. (2015) · Nature Immunology · doi:10.1038/ni.3268 · Cited by 264
Mikhed, Y., Daiber, A., & Steven, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715918 · Cited by 257
“This assumption is in good accordance to the reports on mtROS-driven activation of the inflammasome and expression of proinflammatory cytokines [115–118].”
BackgroundResultLoop Between NLRP3 Inflammasome and Reactive Oxygen Species
Dominic, A., Le, N.-T., & Takahashi, M. (2022) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8257 · Cited by 242
“In addition, it has been shown that DPI, commonly used as a pharmacological inhibitor of NADPH oxidase-derived ROS, can inhibit mtROS at higher doses (10).”
Booshehri, L. M., & Hoffman, H. M. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00638-z · Cited by 239
Urrutia, P. J., Mena, N. P., & Núñez, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00038 · Cited by 243
“…syndrome), exhibit altered mitochondrial function with enhanced mtROS generation and increased production of IL-6, TNFα, and IL-1β; decreasing mtROS levels by the general antioxidant N-acetylcysteine effectively reduces inflammatory cytokine production after LPS stimulation (Bulua et al., 2011).”
BackgroundInflammation and oxidative stress in angiogenesis and vascular disease
Kim, Y.-W., West, X. Z., & Byzova, T. V. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1007-3 · Cited by 242
“One of the signature cellular processes observed during inflammation is respiratory burst, which results in the generation and accumulation of extracellular ROS aimed to protect against invading pathogens [27–29].”
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation
Xu, J., Chi, F., Guo, T., Punj, V., Lee, W. N. P., French, S. W., & Tsukamoto, H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76468 · Cited by 241
“Increased mtROS is seen in M1 Macs and implicated in innate immune function and cytokine expression (38, 39).”
D-mannose induces regulatory T cells and suppresses immunopathology
Zhang, D., Chia, C., Jiao, X., Jin, W., Kasagi, S., Wu, R., Konkel, J. E., Nakatsukasa, H., Zanvit, P., Goldberg, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4375 · Cited by 236
Kesarwani, P., Murali, A. K., Al-Khami, A. A., & Mehrotra, S. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4073 · Cited by 226
“Pharmacological blockade of mitochondrial ROS efficiently reduced inflammatory cytokine production after LPS stimulation, suggesting that mitochondrial ROS may be a novel therapeutic target for TRAPS and other inflammatory diseases.”
BackgroundThe Influence of Gut Microbiota on Oxidative Stress and the Immune System
Kunst, C., Schmid, S., Michalski, M., Tümen, D., Buttenschön, J., Müller, M., & Gülow, K. (2023) · Biomedicines · doi:10.3390/biomedicines11051388 · Cited by 213
“The ROS production is then involved in inducing the activation of the pro-inflammatory proteins IL-1β, IL-6, and TNF [90].”
BackgroundLu, Q.-B., Wan, M.-Y., Wang, P.-Y., Zhang, C.-X., Xu, D.-Y., Liao, X., & Sun, H.-J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.012 · Cited by 231
Dysregulated bioenergetics: a key regulator of joint inflammation
Biniecka, M., Canavan, M., McGarry, T., Gao, W., McCormick, J., Cregan, S., Gallagher, L., Smith, T., Phelan, J. J., Ryan, J., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208476 · Cited by 236
Voloboueva, L. A., Emery, J. F., Sun, X., & Giffard, R. G. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.067 · Cited by 235
“Overall we demonstrate that LPS-induced activation of BV-2 microglial cells promotes not only excessive production of mitochondrial ROS, as has been reported earlier [7,8,10], but also significantly reduces ATP production and increases lactate production.”
Willemsen, J., Neuhoff, M.-T., Hoyler, T., Noir, E., Tessier, C., Sarret, S., Thorsen, T. N., Littlewood-Evans, A., Zhang, J., Hasan, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109977 · Cited by 225
Self-citationKiyuna, L. A., Albuquerque, R. P. E., Chen, C.-H., Mochly-Rosen, D., & Ferreira, J. C. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.019 · Cited by 220
Reactive oxygen species and redox compartmentalization
Kaludercic, N., Deshwal, S., & Di Lisa, F. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00285 · Cited by 205
“Frontiers in Physiology | Mitochondrial Research August 2014 | Volume 5 | Article 285 | 8”
BackgroundYang, E.-J., Kim, S., Kim, J. S., & Choi, I.-H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.016 · Cited by 219
Li, X., Fang, P., Li, Y., Kuo, Y.-M., Andrews, A. J., Nanayakkara, G., Johnson, C., Fu, H., Shan, H., Du, F., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306964 · Cited by 219
“Although mtROS are historically considered to be toxic by-products of mitochondrial metabolism, it has been recently discovered that mtROS are, in fact, signaling molecules that directly contribute to proinflammatory cytokine production,(19) independently of key cytosolic ROS generator, NADPH oxidase.(20) In addition,…”
BackgroundThe Role of Reactive Oxygen Species in Regulating T Cell-mediated Immunity and Disease
Yarosz, E. L., & Chang, C.-H. (2018) · Immune Network · doi:10.4110/in.2018.18.e14 · Cited by 214
“Despite the danger posed by high levels of these compounds, several studies have implicated moderate levels of ROS as critical mediators of intracellular signaling pathways in various cell types (2-5).”
BackgroundNOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 201
“By activating proinflammatory signaling pathways such as NF-kB and MAPKs, ROS not only promotes the production of proinflammatory cytokines such as pro-IL-1b, IL-6 and TNF, but also upregulates NLRP3, a prerequisite for NLRP3 inflammasome assembly [98,172–175].”
BackgroundMolecular basis of asbestos-induced lung disease
Liu, G., Cheresh, P., & Kamp, D. W. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163942 · Cited by 213
Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period
Perez, M., Robbins, M. E., Revhaug, C., & Saugstad, O. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.035 · Cited by 198
Jitschin, R., Hofmann, A. D., Bruns, H., Gießl, A., Bricks, J., Berger, J., Saul, D., Eckart, M. J., Mackensen, A., & Mougiakakos, D. (2014) · Blood · doi:10.1182/blood-2013-10-532200 · Cited by 201
“DPI at the used dosage blocks NOX enzymes without affecting mitochondrial ROS production.(30) Only MitoQ led to a significant reduction (ofmitochondrial and at the same time) of total cellular ROS (Figure 4B).”
Method
Metadata
- Authors
- Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Siegel, Richard M.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-01-31
- Volume
- 208
- Issue
- 3
- Pages
- 519-533
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3058571
- OpenAlex
- W2119828139
- Cited by
- 860
- References
- 65
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 41 · 2023: 58 · 2022: 55 · 2021: 64 · 2020: 58 · 2019: 59 · 2018: 56 · 2017: 65 · 2016: 52 · 2015: 62 · 2014: 65 · 2013: 71 · 2012: 62
- FWCI
- 30.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial reactive oxygen species, tumor necrosis factor receptor-associated periodic syndrome, inflammatory cytokines, lipopolysaccharide response, autoinflammatory disease, NADPH oxidase, gp91phox, p22phox, mitochondrial respiration, MAPK signaling, antioxidants, therapeutic target
- MeSH terms
- Animals, Humans, Inflammation, Mice, Mutant Strains, Mitochondria, Mutation, Nitric Oxide, Signal Transduction, Interleukin-6, Cytokines, Reactive Oxygen Species, Mitogen-Activated Protein Kinase Kinases, Receptors, Tumor Necrosis Factor, Type I, Mice, Cryopyrin-Associated Periodic Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.